SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-032894
Filing Date
2017-06-16
Accepted
2017-06-16 16:48:28
Documents
2
Group Members
ALAIN CAFFIFCPR VENTECH AFCPR VENTECH BFCPR VENTECH COINVESTJEAN BOURCEREAU

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v469118_sc13da.htm SC 13D/A 100546
2 EXHIBIT 1 v469118_ex1.htm EX-99.1 5381
  Complete submission text file 0001144204-17-032894.txt   107560
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88748 | Film No.: 17916676
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 AVENUE DE L?OPERA PARIS I0 75002
Business Address 47 AVENUE DE L?OPERA PARIS I0 75002 01-83-79-81-91
Ventech Capital II (Filed by) CIK: 0001604072 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A